✦ LIBER ✦

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis

✍ Scribed by N. Putzki; K. Kollia; S. Woods; E. Igwe; H. C. Diener; V. Limmroth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How effective is natalizumab as second-l

✍ P. S. Sorensen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Efficacy of natalizumab in second line t

✍ N. Putzki; O. Yaldizli; M. Mäurer; S. Cursiefen; S. Kuckert; C. Klawe; M. Maschk 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

PND25 ECONOMIC EVALUATION OF NATALIZUMAB

✍ C Brennig; E Walter; V Schöllbauer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PND23 Economic Evaluation of Natalizumab

✍ S.T. Alexopoulos; B. Deniz; A.R. Walker; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Effect of natalizumab on clinical and ra

✍ Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; C 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB

PND28 Cost-Effectiveness Analysis of Int

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB